COMMUNIQUÉS West-GlobeNewswire

Catalyst Biosciences Reports Second Quarter Operating & Financial Results and Provides Corporate Update

02/08/2018 - 14:00

Announced Positive Interim Data from a Phase 2/3 Study of Marzeptacog Alfa (Activated) (FVIIa) in Individuals with Hemophilia A or B with Inhibitors Presented CB 2679d (FIX) Phase 1/2 Data at the World Federation of [...]

Alder BioPharmaceuticals® to Present at the Canaccord Genuity 38th Annual Growth Conference

02/08/2018 - 14:00

BOTHELL, Wash., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]

Caladrius Biosciences to Host Second Quarter 2018 Financial Results Conference Call on Thursday, August 9, 2018 at 4:30 p.m. ET

02/08/2018 - 14:00

BASKING RIDGE, N.J., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq:CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company with multiple technology platforms targeting [...]

Daré Bioscience, Inc. to Present at the Canaccord Genuity 38th Annual Growth Conference

02/08/2018 - 14:00

SAN DIEGO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a clinical-stage, women’s biopharmaceutical company, today announced that John Fair, Chief Business Officer, will present at the [...]

CASMED Reports Second Quarter 2018 Financial Results

02/08/2018 - 14:00

Achieves 20% U.S. FORE-SIGHT® sales growth, expands gross margin, narrows operating loss Conference Call Begins at 10:00 a.m. Eastern Time Today BRANFORD, Conn., Aug. 02, 2018 (GLOBE NEWSWIRE) -- CAS Medical Systems, [...]

Fibrocell to Host Conference Call and Webcast on Thursday, August 9, 2018 to Discuss Second Quarter 2018 Financial Results and Recent Highlights

02/08/2018 - 14:00

EXTON, Pa., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, will [...]

Selecta Biosciences to Present at the Canaccord Growth Conference on August 9, 2018

02/08/2018 - 14:00

WATERTOWN, Mass., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq:SELB), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by mitigating [...]

Opiant Pharmaceuticals to Report Second Quarter 2018 Financial Results and Host Conference Call and Webcast on Thursday, August 9

02/08/2018 - 14:00

SANTA MONICA, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") (NASDAQ:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions and drug overdose, [...]

Forty Seven Inc. to Present at the 38th Annual Canaccord Genuity Growth Conference

02/08/2018 - 14:00

MENLO PARK, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Forty Seven Inc. (NASDAQ:FTSV), a clinical-stage, immuno-oncology company focused on developing therapies to activate macrophages in the fight against cancer, today [...]

Momenta Pharmaceuticals Announces Date of Second Quarter 2018 Financial Results Conference Call and Webcast

02/08/2018 - 14:00

CAMBRIDGE, Mass., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), today announced that it will release its financial results for the second quarter ended June 30, 2018 and provide a [...]

Savara to Host Second Quarter 2018 Financial Results and Business Update Conference Call on Thursday, August 9, 2018

02/08/2018 - 14:00

AUSTIN, Texas, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Savara Inc. (NASDAQ: SVRA), an orphan lung disease company, today announced it will release its second quarter 2018 financial results on Thursday, August 9, 2018. Savara [...]

Jounce Therapeutics to Announce Second Quarter 2018 Financial Results and Host Conference Call on Thursday, August 9, 2018

02/08/2018 - 14:00

CAMBRIDGE, Mass., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, [...]

Evelo Biosciences Reports Second Quarter 2018 Financial Results and Recent Business Highlights

02/08/2018 - 14:00

-- Advancing Multiple Product Candidates into Clinical Trials with Dosing of First Patient in Phase 1 Trial of EDP1066 in Psoriasis and Atopic Dermatitis and FDA Acceptance of IND for Phase 2a Investigator-Sponsored [...]

OPKO Health to Announce Second Quarter 2018 Financial Results on August 7, 2018

02/08/2018 - 14:00

MIAMI, Aug. 02, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to announce its operating and financial results for the three and six months ended June 30, 2018 after the close of the U.S. financial [...]

Obalon Announces Second Quarter 2018 Financial Results

02/08/2018 - 14:00

SAN DIEGO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon [...]

Aptinyx Initiates Phase 1 Study of NYX-458

02/08/2018 - 14:00

Development in Parkinson’s Disease Cognitive Impairment Planned EVANSTON, Ill., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Aptinyx Inc. (NASDAQ:APTX), a clinical-stage biopharmaceutical company developing transformative [...]

Photocure ASA: Presentation of the second quarter and first half year 2018 results

02/08/2018 - 08:11

Photocure will present its second quarter and first half year report on Wednesday 8 August 2018 at Hotel Continental, Oslo, Norway. The presentation will begin at 08:30 (CET) and representatives from the company will be [...]

Shire plc : Rule 2.9 Announcement

02/08/2018 - 08:01

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 2 August 2018 [...]

Press Release: Terveystalo sells its Riga based subsidiary Ava Clinic

02/08/2018 - 08:01

On 31 July 2018, Terveystalo Group has entered into an agreement with Eugin Group, Europe's second largest group fully dedicated to human reproduction, whereby Terveystalo sells to Eugin Group the entire operation of [...]